Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based Approach study

[1] Larney S(2017)A systematic review of injecting-related injury and disease among people who inject drugs Drug Alcohol Depend 171 39-49

[2] Peacock A(2022)The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: a retrospective data linkage study Drug Alcohol Depend 236 109494-73

[3] Mathers BM(2023)Community-acquired skin and soft-tissue infections in people who inject drugs Curr Opin Infect Dis 36 67-1924

[4] Hickman M(2021)Injecting drug use, the skin and vasculature Addiction 116 1914-S7

[5] Degenhardt L(2009)Skin and soft tissue infection: microbiology and epidemiology Int J Antimicrob Agents 34 S2-16

[6] Colledge-Frisby S(2009)Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users Drug Alcohol Depend 100 9-1403

[7] Jones N(2017)Opiate injection-associated skin, soft tissue, and vascular infections, England, UK, 1997–2016 Emerg Infect Dis 23 1400-72

[8] Larney S(2020)Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: a comparative examination of data from two surveys Drug Alcohol Depend 213 108080-97

[9] Peacock A(2020)Normalised pain and severe health care delay among people who inject drugs in London: adapting cultural safety principles to promote care Soc Sci Med 260 113183-1096

[10] Lewer D(2019)The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: a qualitative study Int J Drug Policy 65 65-106

[1] Larney S(2017)A systematic review of injecting-related injury and disease among people who inject drugs Drug Alcohol Depend 171 39-49

[2] Peacock A(2022)The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: a retrospective data linkage study Drug Alcohol Depend 236 109494-73

[3] Mathers BM(2023)Community-acquired skin and soft-tissue infections in people who inject drugs Curr Opin Infect Dis 36 67-1924

[4] Hickman M(2021)Injecting drug use, the skin and vasculature Addiction 116 1914-S7

[5] Degenhardt L(2009)Skin and soft tissue infection: microbiology and epidemiology Int J Antimicrob Agents 34 S2-16

[6] Colledge-Frisby S(2009)Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users Drug Alcohol Depend 100 9-1403

[7] Jones N(2017)Opiate injection-associated skin, soft tissue, and vascular infections, England, UK, 1997–2016 Emerg Infect Dis 23 1400-72

[8] Larney S(2020)Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: a comparative examination of data from two surveys Drug Alcohol Depend 213 108080-97

[9] Peacock A(2020)Normalised pain and severe health care delay among people who inject drugs in London: adapting cultural safety principles to promote care Soc Sci Med 260 113183-1096

[10] Lewer D(2019)The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: a qualitative study Int J Drug Policy 65 65-106